AS49274 — TAKEDA-GERMANY Takeda GmbH

AS49274 announces 3 IPv4 prefixes covering 1,024 addresses and 0 IPv6 prefixes.

About this network

TAKEDA-GERMANY is operated by Takeda GmbH, the German subsidiary of the global pharmaceutical company Takeda.

What it's used for

• The address space carries internal corporate infrastructure for Takeda's German manufacturing and administrative operations, with no public-facing service indicators in the netnames.
• The AS announces 1024 IPv4 addresses across 3 prefixes and maintains 2 observed neighbours, a ratio consistent with a small internal corporate estate rather than a transit or access network.
• Traffic from this AS consists of office workers, manufacturing facility systems, and internal corporate endpoints supporting Takeda's pharmaceutical production sites in Germany.

Notable

• Registrants do not fully align with the announcer: the 63.244.242.0/23 and 63.244.241.0/24 blocks are registered to Millennium Pharmaceuticals, Inc. under the netname MPINET, while 163.144.254.0/24 is registered to IRT-JPNIC-JP under the netname JAPAN163.
• Takeda GmbH is part of Takeda's global production network, with manufacturing facilities in Oranienburg, Brandenburg, and Singen, Germany.
• The address inventory is small and fragmented, consisting of two blocks from the 63.244.0.0/16 range and one from the 163.144.0.0/16 range, typical of a corporate network that has accumulated space through acquisitions or historical allocations.

This description is AI-generated, best-effort context — not authoritative, and provided without any guarantee of accuracy.

Announced prefixes

• 63.244.241.0/24
• 63.244.242.0/23
• 163.144.254.0/24

Upstream networks

• AS5511 Orange S.A.
• AS4713 NTT DOCOMO BUSINESS,Inc.

Adjacent networks

• AS5511 Orange S.A.
• AS4713 NTT DOCOMO BUSINESS,Inc.

Routing security

• RPKI: 0 valid, 0 invalid and 4 not-found announcements; 0 ROAs.
• ASPA: none published.
• IRR: 0% of announcements registered; 0 route objects.
• Listed in as-sets: AS-OCN, AS-OCN, AS-OPENTRANSIT.